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PENENTUAN PETANDA BIOMOLEKUL DI DALAM PROGNOSIS KANSER 
SERVIKS 
 
 
ABSTRAK 
 
 
Faktor biomolekul dijangka dapat membaiki dan meningkatkan ramalan berkaitan 
diagnosis dan prognosis dalam kanser. Pemahaman tentang tapak jalan khusus 
biomolekul akan meningkatkan lagi keupayaan terapi dalam penyembuhan kanser 
serviks agar pengubahsuaian kaedah terapi dapat dibuat mengikut kesesuaian 
individu. Kajian telah menunjukkan pengiraan salur darah mikro (MVD), kadar 
pengekspresan protein cyclooxygenase-2 (COX-2), E-cadherin, human telomerase 
reverse transcriptase (hTERT) dan Insulin-like growth factor receptor (IGF-R) 
mempunyai peranan penting dalam perkembangan sel kanser dan di dalam 
meramalkan prognosis pesakit kanser serviks. Pembahagian sel kanser adalah 
berlebihan dan tidak terkawal serta memerlukan hanya sedikit faktor pertumbuhan 
kerana sel kanser mempunyai pengekspresan IGF-R yang berlebihan. 
Walaubagaimanapun tumor tidak dapat membesar melebihi 1-10mm3 sekiranya 
tidak terdapat sistem vaskular yang menyediakan salur darah mikro melalui proses 
angiogenesis. Tambahan pula peningkatan pengekspresan protein COX-2 
merencat proses apoptosis dan meningkatkan proses angiogenesis serta 
perebakan tumor. Tumor malignan mempunyai potensi metastasis yang tinggi 
kerana perlekatan antara sel-sel tumor adalah lemah disebabkan oleh 
pengekspresan E-cadherin yang rendah. Sel kanser juga tidak melalui proses 
replikasi senesen dalam setiap peringkat pembahagian sel kerana enzim hTERT 
yang berlebihan sentiasa mensintesis telomerase baru yang menghalang proses 
apoptosis dari berlaku. Kajian retrospektif ini menggunakan sampel serviks normal, 
  xvii 
sampel neoplasia intraepithelial serviks (CIN) dan kanser serviks yang telah 
didiagnosis secara histologi dari tahun 1998 hingga 2003 di HUSM. Kaedah 
immunohistokimia telah digunakan ke atas semua sampel untuk pengiraan MVD 
dan menganggarkan peratusan pengekspresan COX-2, E-cadherin, hTERT dan 
IGF-R. Kajian ini mendapati bahawa terdapat peningkatan signifikan (p<0.001) 
dalam MVD, COX-2, E-cadherin, hTERT dan IGF-R pada peringkat kanser yang 
lebih tinggi. Walaubagaimanapun terdapat penurunan yang signifikan bagi 
pengekspresan E-cadherin (p<0.001) di dalam sampel kanser berbanding sampel 
normal dan CIN. Kami juga mendapati bahawa faktor MVD adalah paling berkaitan 
dengan beberapa faktor klinikal termasuk status metastasis nodus limfa (p=0.005), 
penglibatan parametrium (p=0.003), penglibatan ruang vaskular (p=0.004), status 
kemasukan stroma (p=0.003) dan status pembezaan sel kanser (p=0.002). 
Pengekspresan protein COX-2 pula menunjukkan perkaitan yang signifikan 
dengan status metastasis nodus limfa (p=0.006), penglibatan parametrium (p= 
0.004) dan status pembezaan sel (p=0.001). Pengekspresan proten E-cadherin, 
hTERT dan IGF-R pula didapati hanya berkaitan dengan status metastasis nodus 
limfa dan status pembezaan sel tumor (p<0.05). Kemandirian pesakit kanser 
serviks didapati berkaitan dengan MVD, status pembezaan sel tumor, status 
metastasis nodus limfa dan status kemasukan ruang stroma (p<0.05). Bagi 
kemandirian terhadap penyakit, kami mendapati  kadar pengekspresan COX-2, 
status kemasukan stroma, penglibatan ruang vaskular dan kemasukan parametrial 
adalah faktor prognosis yang signifikan bagi pesakit kanser serviks. 
Kesimpulannya, pengiraan salur darah mikro (MVD), kadar pengekspresan protein 
cyclooxygenase-2 (COX-2), E-cadherin, human telomerase reverse transcriptase 
  xviii 
(hTERT) dan Insulin-like growth factor receptor (IGF-R) ini diekspreskan dalam 
kadar yang berbeza pada peringkat histologi yang berlainan dalam kanser serviks 
dan berpotensi sebagai petanda diagnosis dan prognosis dalam kanser.   
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DETERMINATION OF PROGNOSTIC MARKERS IN CERVICAL CANCER 
 
ABSTRACT 
 
Biomolecular factors could possibly improve the prediction of prognosis and 
diagnosis in cancer. Understanding specific molecular pathways could possibly 
shed some light in improving therapeutic modalities so that the treatment plan can 
be modified to suit individual cases. Various markers including factor VIII related  
antigen (MVD), Cyclooxygenase-2 (COX-2), E-cadherin, human telomerase 
reverse transcriptase (hTERT) and insulin like growth factor receptor (IGF-R) have 
been shown to play important roles in carcinogenesis and in predicting the 
prognosis of cervical cancer. Proliferation of tumor cells is uncontrolled, excessive 
and requires less growth factor since tumor cells have aberrant expression of IGF-
R. However, tumor cells cannot grow more than 1-10mm3 unless it is vascularised 
through angiogenesis by the formation of microvessels. Furthermore high 
expression of COX-2 suppress apoptosis, promote angiogenesis and tumor 
invasion. Malignant tumor cells have high metastatic potential because the cells 
are less adherent to each other as a result of decreased expression of E-cadherin. 
Cancer cells also do not undergo replicative senescence during each cell division 
because the hTERT enzyme synthesizes new telomerase and prevent apoptosis. 
This retrospective study was done among normal cervix, cervical intraepithelial 
neoplasia (CIN) and squamous cell carcinoma (SCC) of cervix which have been 
histopathologically diagnosed from year 1998 to 2003 in HUSM. All samples were 
subjected to immunohistochemistry approach to quantify the microvessel density 
  xx 
(MVD) and to estimate the percentage of the expression of COX-2, E-cadherin, 
hTERT and IGF-R. Our results revealed that there were significantly increased 
expression of MVD, COX-2, hTERT and IGF-R as the disease become more 
cancerous (p<0.001). However, decreased expression of E-cadherin were seen in 
SCC samples compared to normal and CIN samples (p<0.001). MVD expression 
has been shown to be the most related with all clinical and clinicopathological 
parameters including lymph node metastasis (p=0.005), parametrial involvement 
(p=0.003), vascular space involvement (p=0.004), deep stromal invasion (p=0.003) 
and tumor differentiation (p=0.002). While COX-2 protein expression showed a 
significant correlation with lymph node metastasis (p=0.006), parametrial 
involvement (p=0.004) and tumor differentiation status (p= 0.001). E-cadherin, 
hTERT and IGF-R protein expression showed significant correlation only with 
lymph node metastasis and tumor differentiation (p<0.05). For overall survival, our 
results showed that MVD, tumor differentiation, lymph node status and deep 
stromal invasion were significant prognostic markers (p<0.05). For disease free 
survival we found that COX-2 protein expression, deep stromal invasion, vascular 
space involvement and parametrial involvement was a good prognostic markers 
(p<0.05). It is concluded that factor VIII related antigen (MVD), Cyclooxygenase-2 
(COX-2), E-cadherin, human telomerase reverse transcriptase (hTERT) and insulin 
like growth factor receptor (IGF-R) are expressed in different histological stages of 
cervical cancer and may have potential values to be used as diagnostic or 
prognostic marker in cervical cancer. 
 1
CHAPTER 1 
INTRODUCTION 
 
1.1 Anatomy and physiology of the cervix 
   
 Cervix is a Latin word meaning the neck, thus cervix is the neck of the 
uterus. Cervix serves as a canal between the uterus and vagina.  The adult cervix 
is cylindrical in shape. Figure 1.1 show anatomy of the cervix. The portion that 
projects into the vagina is called the ectocervix which consisting of anterior and 
posterior lips, contains an external os roughly in the center. The cervix is 2.5 to 
3.0cm in length and 2.5cm in diameter in nulliparous women. While in 
multiparous woman, the cervix is larger and has a slit like horizontal os and 
healed lacerations may be present (Yao et al., 2002). Normal cervix has a 
smooth, glistening mucosal surface while cervix with squamous cell carcinoma 
usually appeared as a fungating red to yellow mass (Figure 1.2 and 1.3). 
  
 The cervix has several important functions. It acts as barrier between the 
sterile endometrial cavity and the bacteria-laden vagina. The alkaline to neutral 
cervical mucus inhibits vaginal floras, which generally favour an acid 
environment. The function of the cervix is to allow flow of menstrual blood from 
the uterus into the vagina, and direct the sperms into the uterus during 
intercourse. The physical, biochemical and immunologic properties of the cervical 
mucus are important for sperm transport (Iwasaka et al., 1998).  
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During pregnancy, the cervix becomes enlarged as a result of edema and 
increased vascularity in the stroma. The squamous mucosa is thickened, and 
endocervical epithelium often extends onto the ectocervix. The opening of the 
cervical canal is normally very narrow. However under the influence of the body 
hormones and the pressure from the fetal head, this opening widens to about 4 
inches during labor, to allow the birth of a baby. The isthmus acts as a sphincter  
during childbirth (Yao et al., 2002). 
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Figure 1.1 The anatomy of the cervix 
(http://www.medindia.com/patients/patientinfo/images/cervix.gif) 
 
 
Figure 1.2 Normal cervix 
(http:www.embryologist.com/images/femorgs.html) 
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Figure 1.3 Cervical carcinoma 
(http:www.gfmer/ch/selected_images_v2/detail_list.php) 
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1.2 Neoplasm 
 
Neoplasm is a collection of diseases in which cell growth and division are 
unregulated. Classification of cancer is made according to the site of origin, 
histology and the extent of the disease. Without regulation, cells divide 
ceaselessly, piling up on top of each other to form tumors. When cells detach 
from a tumor and invade the surrounding tissues, the tumor is malignant, which is 
commonly termed as cancer. When the cells do not invade the surrounding 
tissues, the tumor is benign. Malignant tumor may spread through the 
bloodstream and lymphatic system to other parts of the body forming secondary 
tumors. This process is called metastasis. (Hopman et al., 2004).  
  
 Malignant neoplasms are characterized by a wide range of parenchyma 
cell differentiation, from well differentiated to completely undifferentiated. 
Malignant neoplasm that are composed of undifferentiated cells are said to be 
anaplastic (Woerner et al., 1995). Lack of differentiation or anaplasia is 
considered a hallmark of malignancy (Schneider et al., 2002). Malignant 
neoplasm arises from a single cell which has undergone mutation. Mutations in 
genes give the cell increased growth advantages compared to others and allow 
them to escape normal controls on proliferation (Oliver et al., 1998). The initial 
mutation will cause cell to divide to produce a genetically homogenous clone. 
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 A tumor is said to be benign when its microscopic and gross 
characteristics are considered relatively innocent; implying that it will remain 
localized, it cannot spread to other sites, and it is generally amenable to local 
surgical removal and the patients usually survive (Schneider et al., 2002). Benign 
neoplasms are rarely life threatening, grow within a well defined capsule which 
limits their size and maintain the characteristics of the cell of origin and are thus 
usually well differentiated. Benign neoplasms are composed of well-differentiated 
cells that closely resemble their normal counterparts (Hopman et al., 2004). 
 
 Tumor cells show a number of features which differentiate them from 
normal cells. They are no longer as dependent on growth factors as normal cells 
either because they are capable of secreting their own growth factors to stimulate 
their own proliferation, a process termed autocrine stimulation or because growth 
factor receptors on the surface are altered in such a way that binding of growth 
factor is no longer necessary to stimulate proliferation (Schneider et al., 2002). 
  
Tumor cells also differ than normal cells because they are anchorage 
independent while normal cells require contact with the surface in the extra 
cellular environment to be able to grow. Normal cells respond to the presence of 
other cells, and in culture will form a monolayer due to contact inhibition, whereas 
tumor cells lack this and often grow over or under each other (Wong et al., 2000). 
Normal cells stop proliferating once they reach a certain density but tumor cells 
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continue to proliferate. Study also found that tumor cells are less adhesive than 
normal cells (Macdonald et al., 2000). 
 
 
1.2.1 Cancer in Malaysia 
 
A total of 21 464 cancer cases were diagnosed among Malaysian in 
Peninsular Malaysia in the year 2003, comprising 9 400 males and 12 064 
females. The crude rate for males was 97.4 per 100 000 populations and 127.6 
per 100 000 population for females. Cancer occurred at all ages. The median 
age at diagnosis for cancer in Malaysian males was 59 years and 53 years for 
Malaysian females. The five most frequent cancers in men were nasopharynx, 
leukaemia, lymphoma, lung, colon and rectum while cancer of the breast, cervix, 
ovary, uterus, thyroid gland and leukemia in woman (National Cancer Registry, 
2003).  
 
Cervical cancer is the second most common female cancer in the world 
after breast cancer. Cervical cancer is reported as being particularly common in 
less developed countries, including Southeast Asia. The incidence in Malaysia is 
19.7 per 100,000 populations (National Cancer Registry, 2003). For the past 
twenty years or so the annual Reports of Ministry of Health recorded an average 
of 2 200 new cases per year (Ministry of Health Annual Reports 1980-2000). 
Cervical cancer incidence rate increased with age after 30 years. It has a peak 
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incidence rate at age 60-69 years, and declined thereafter (National Cancer 
Registry, 2003). 
 
1.2.2 Cervical cancer 
  
Cervical cancer develops in the lining of the cervix, the lower part of the 
uterus that enters the vagina. Cervix normally looks smooth, shining, and moist 
with thin film of mucus coating the surface, but it will look florid exophytic 
cauliflower-like growth when it become cancerous (Nor Hayati, 2003). Cervical 
cancer is thought to develop through a multistep process in which increasing 
severely premalignant dysplastic lesion called cervical intraepithelial neoplasia 
(CIN) I, II, III and carcinoma in situ progress to invasive carcinoma. Low grade 
CIN indicates a minimal change in the cells and high-grade CIN indicates a 
greater degree of abnormality (Iwasaka et al., 1998). 
 
 Cervical cancer develops in the epithelia of the neck of the uterus from a 
single cell undergoing neoplastic transformation. Most of the time the process is 
initiated in a peculiar anatomical region known as transitional or transformation 
zone where the columnar epithelium of the inner part of the cervix, the 
endocervix merges with the nonkeratinizing squamous epithelium of the external 
part of the cervix, the ectocervix. It has been established the invasive cancer is 
the final stage of a continuous process historically described as a series of 
discrete stages (Woodman et al., 2001).  
 9
 
 The association of HPV infection and cervical cancer is stronger than that 
between cigarette smoking and lung cancer. HPV infection is very common and it 
is the most common sexually acquired viral infection. There are more than 130 
subtypes of HPV and about 70 subtypes infect human and 35 of them infect 
genital tract. In the presence of HPV, the benign metaplastic process is diverted 
into malignant transformation of CIN and then, in an unknown proportion of 
women, progressing to invasive squamous cell carcinoma (Bornstein et al., 
1995). 
 
Treatment of locally advanced cervical cancer consists of radiotherapy 
and chemotherapy. However, results are better with this combination than with 
radiotherapy alone. The treatment still results in substantial morbidity (Maduro et 
al, 2003). Long term toxic effects of chemoradiotherapy in cervical cancer are still 
unclear because of the short follow-up of these patients. Further improvement in 
survival through intensifications of the standard treatment is limited by intrinsic 
and acquired tumor resistence, and short term and long term side effects. Tumor 
resistance is commonly caused by a loss of the tumor cells ability to enter 
apoptosis (Iwasaka et al., 1998). 
 
Understanding of specific molecular pathways leading to increased cell 
death could widen the therapeutic window. Better knowledge of the molecular 
mechanisms that underlie the apoptosis process should enable modulation of 
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this apoptotic pathway and might improve the treatment results. Combination of 
cell death by necrosis, which is commonly induced by radiotherapy, with cell 
death through apoptosis, might lead to higher overall tumor cell kill (Lyng et al., 
2000).   
 
1.2.3 Human papillomavirus (HPV) 
 
 Human papilloma viruses are small, double stranded DNA viruses with a 
circular genome of about 7 900 nucleotide base pairs. Cervical infection by 
specific genital HPV types is a precursor event in the development of cervical 
cancer (Zeng et al., 2002). Genital HPV types are divided into groups based on 
the frequency of association with malignant tumors. Viral subtypes with high risk 
oncogenic potential include HPVs 16, 18, 45 and 56 (Munoz et al., 2003). Eleven 
subtypes are of intermediate risk for the development of neoplasia (HPVs 31, 33, 
35, 39, 51, 52, 55, 58, 59, 66 and 68) and eight subtypes are of low risk (HPVs 6, 
11, 26, 42, 44, 54, 70 and 73) (Joshi et al., 2005).  
 
It was shown that more than 90% of cervical cancers contain HPV DNA so 
HPV infection can be viewed as a necessary cause of cervical cancer (Joshi et 
al., 2005). According to a proposed scheme for the natural history of HPV 
infection and cervical neoplasia, transient genital HPV infection commonly 
develop in women after the initiation of sexual intercourse. The prevalence of 
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genital HPV infection is highest in sexually active women in their teens and 
twenties and decreased markedly after age 30 years (Kumar et al., 2003a).  
  
Infection of HPVs causes dysplastic lesions in the cervical epithelium that 
in many cases are self limiting, demonstrating effective host immune response to 
the virally infected cells (Joshi et al., 2005). However in some cases, the immune 
system fails to clear the infection which may become chronic and eventually lead 
to growth of malignant cells and the development of invasive cancer. It is evident 
that the majority of high risk HPV infections do not progress malignancy (Bosch 
et al., 2002). Other risk factor  for malignant change are needed such as high 
viral load, p53 polymorphisms, immunosuppression, tobacco usage, multiple 
sexual partner and possibly synergistic effect of other concurrent viral infections 
such as herpes simplex (Kumar et al., 2003a). 
 
The mechanism by which some viral infection remain low risk and some 
are high risk for developing high grade CIN or invasive cancer are different. In 
HPV infected lesions, the low risk viral DNA remains structurally as episomes. In 
the invasive cancers, the viral genome is usually found integrated into chromatin 
material of the host nucleus. In brief, much of current research shows that HPV 
interacts with host proteins to deregulate the cell cycle (Munoz et al., 2003). 
 
 In the normal cell, an antioncogene such as retinoblastoma gene acts as 
a functional brake on cell division. E7 and related transforming proteins 
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competitively bind with retinoblastoma gene and inactivating it (Sherbet & Patil, 
2003). Similarly a suppressor gene, p53 acts normally to suppress growth of 
tumor cells. The binding of the viral E6 oncoprotein in high risk HPV types with 
host cell protein, p53 promotes degradation of p53, which is functionally 
equivalent to mutational inactivation. Thus inhibition of cell growth is again lost, 
which represents an endogenous progression factor that important in the 
carcinogenic process (Furumoto & Irahara, 2002). 
 
1.3 Immunohistochemistry in cancer research 
 
Immunohistochemistry is a method for localizing specific antigens in 
tissues based on antigen-antibody recognization and it seeks to exploit the 
specificity provided by the binding of an antibody with its antigen at a light 
microscopic level. It has a long history, extending more than half a century from 
1940. However, only since the early 1990s has the method found general 
applications in surgical pathology (Talbot et al., 2004). 
 
Immunohistochemical technique is a specialized technique used to identify 
specific substances in tissue using derived antibodies and detection systems that 
allow visual identification. The identification of specific compounds enables the 
physician to determine more accurately the histogenesis of particular lesions and 
possibly provides prognostic information about them as well. Antibody molecules 
cannot be seen with the light microscope or even with the electron microscope 
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unless they are labeled or flagged by some methods that permit their 
visualization. Essentially, detection systems attach certain labels or flags to 
primary or secondary antibodies in order to visualize the target antibody-antigen 
localization in the tissue sections (Lee et al., 2003). 
 
Immunohistochemistry staining is based on affinity between antigens and 
antibodies, which can be demonstrated by immunoflourescence technique or 
immunoenzyme technique (Farley et al., 2000). Antibodies are raised against 
antigenic determinants present on the compound in tissue and are detected by 
the use on the antibodies that are designed to recognize the immunoglobulin 
from the species exposed to the original compound. These detection antibodies 
(anti-antibodies from other species) are tagged with some reporter molecule such 
as fluorescein or enzyme that can catalyze a further reaction towards a visible 
product (Stabenow et al., 2005). 
 
Immunoflourescence techniques involve two major types of labelling 
systems, either direct or indirect methods. The direct methods give a direct 
visualization of antigen or antibody by treatment of sample solution containing 
flourochrome labelled antibody. In the indirect method, samples are treated with 
unlabeled specific antibody for a particular antigen and followed by treatment 
with flourochrome labelled antibody specific for the first antibody (Leong et al., 
2002). 
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In the immunoenzyme technique, for both direct and indirect methods, 
enzyme can be used as an alternative to fluorochrome to detect the antigens or 
antibody. Variation of immunoenzyme staining includes enzyme labelled antibody 
direct or indirectly and unlabeled antibody enzyme procedure or known as three 
layer techniques such as PAP (Peroxidase anti-peroxidase), APAAP (Alkaline 
phosphatase anti-alkaline phosphatase), and the Avidin-biotin-complex (ABC) 
method (Vasdev & Nayak., 2004). 
 
The Avidin-biotin complex (ABC) or other methods of detection system is 
used on specimen of paraffin embedded tissue. The specific antibody to the 
compound of interest is allowed to combine with the antigen and is detected with 
an anti-antibody produced in another species that recognizes the first antibody as 
an antigen. This secondary antibody has biotin molecules attached to it, enabling 
further detection with the protein avidin (Vieira et al., 2004). 
 
Biotin is a vitamin which is relatively small and its attachment to the chains 
of the immunoglobulin does not interfere with its ability to recognize the primary 
antibody. Avidin has a high affinity for the biotin molecule and the combination is 
virtually irreversible. Each avidin molecules has four combination sites for biotin, 
and each biotin molecule has two combination sites for avidin (Dabbs., 2002). 
The horseradish peroxidase (HRP) molecule is used as reporter molecule. This 
enzyme is bound by biotin and incorporated in an avidin-biotin complex in such a 
way that, when it is brought in proximity to the secondary biotinylated anti-
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antibody, the complex binds through a remaining bind-binding site on one of the 
avidin molecules (Stabenow et al., 2005). 
 
This essentially provides the enzyme at the site of the original primary 
antibody-antigen interaction. The enzyme then, acting on hydrogen peroxide, 
promotes the transfer of electrons from a chromogenic compound that 
precipitates as an insoluble pigment. The chromogen in use is 3,3’-
Diaminobenzidine tetrahydrochloride (DAB). This molecule is essentially 
colorless in solution at dilute concentrations and precipitate dark brown during 
the oxidation. The precipitate is insoluble in alcohol, allowing the section to be 
counterstained with haematoxylin, dehydrated with ethanol, cleared with xylene 
and coverslipped (Nakano et al., 1990). 
 
1.4 Prognostic markers in cervical cancer 
 
 Prognosis can be defined as an expert prediction of outcome which is 
based on an accurate diagnosis, knowledge of the natural history of the disease, 
the disease’s response to treatment and the progression of the disease in the 
patient in question (Kenneth, 1995). Knowledge of prognostic factors could help 
in tailoring treatment so that overtreatmet can be avoided in low risk groups and 
adjuvant treatment only be given to patients with a high risk of relapse. Factors 
that are often been used as prognostic factors includes pelvic lymph node 
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metastasis, tumor diameter, deep stromal invasion and close resection margins 
(Kruse et al., 2004). 
 
In cervical cancer, clinical stage is the principal prognostic factor that has 
been used. Other factors that are frequently identified as prognostic for 
diminished survival include increasing tumor size and number of involved lymph 
nodes, adenocarcinoma histology versus squamous cell cancers, and lymph-
vascular space invasion (Lee et al., 2002a). Among the biological features that 
may have a predictive role in cancer of the cervix are haemoglobin level, tumor 
oxygenation status, squamous cell carcinoma antigen, HPV serotype, tumor 
vascularity, proliferative index and p53 mutation (Lyng et al., 2000). Until now no 
adequate parameters are available in predicting the survival of the cervical 
cancer patients. Other more accurate prognostic parameters will allow not only 
improved understanding of the biologic behavior of the tumor but also could help 
define a subgroup of patients at risk for recurrence, which make it possible for 
individualized treatment (Woodman et al., 2001).  
 
Biomolecular factors could possibly improve the prediction of prognosis 
and diagnosis in cancer. Because of their role in tumorigenesis lead to 
development of new treatment strategies. Among the potential prognostic 
markers being studied in the present include angiogenesis, cyclooxygenase-2, E-
cadherin, human telomerase reverse transcriptase (hTERT) for telomerase 
activation and insulin like growth factor receptor (IGF-R).  
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We embarked on this study in order to determine the 
immunohistochemical expression of the above biological markers in different 
histological diagnosis of cervices samples. The hypotheses of this study are: 
 
a) The number of microvessel density (MVD) and the percentage of 
expression of COX-2, hTERT, IGF-R will be directly proportional to the 
grade of the tumor and inversely proportional to the prognosis. 
b) E-cadherin protein expression is inversely proportional to the grade of 
the tumor and the prognosis. 
c) There is an association between the MVD, COX-2, E-cadherin, hTERT 
and IGF-R protein expression with clinical and clinicopathological factors 
of cervical cancer. 
 
1.5 Research Objective 
 
The general objective of this study was to determine the prognostic 
markers in cervical cancer. 
 
The specific objectives are: 
a) To quantify the microvessel density (MVD) and to estimate the percentage of 
the expression of insulin like growth factor receptor (IGF-R), cyclooxygenase-2 
(COX-2), E-cadherin and human telomerase reverse transcriptase (hTERT) in 
normal cervix, cervix with CIN, cervix with HPV infection and cervix with SCC.  
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b) To determine whether the MVD, the percentage of the expression of IGF-R, 
COX-2, E-cadherin and hTERT can predict the risk of recurrence in CIN patients. 
 
c) To investigate the association between MVD, IGF-R, COX-2, E-cadherin and 
hTERT with tumor differentiation, deep stromal invasion, parametrial 
involvement, vascular space involvement and lymph node metastasis in patients 
with SCC. 
 
d) To investigate the association between MVD, IGF-R, COX-2, E-cadherin, 
hTERT, tumor differentiation, deep stromal invasion, parametrial invasion, 
vascular space involvement and lymph node metastasis in SCC’s patients with 
prognosis of the patients. 
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CHAPTER 2 
 
ANGIOGENESIS 
 
 
 
2.1 Introduction: Angiogenesis in cervical cancer 
 
 
 
Angiogenesis is the development of new blood vessels from preexisting 
capillaries. It is essential in tissue development, reproduction and wound healing 
(Branca et al., 2006c). However unregulated angiogenesis seem to play a critical 
role in several diseases including diabetes, arthritis and neoplasia. Angiogenesis 
has also been associated with the prognosis of neoplasm. Studies found that 
tumor with high microvessel density (MVD) seem to have a worse prognosis than 
those with low microvessel density.  
 
Angiogenesis is essential for the development, growth and advancement 
of solid tumors (Abulafia & Sherer, 2000). Angiogenesis is induced by hypoxia 
with angiogenic transcription factor hypoxia inducible factors (HIF) (Fujita et al., 
2006). Tumor angiogenesis is a complex multistep process and arises from an 
imbalance between positive and negative angiogenic stimuli. Several factors 
induce angiogenesis, but most important is basic fibroblast growth factor (bFGF) 
and vascular endothelial growth factor (VEGF). Although multiple cell types 
produce the angiogenic factors, the receptors are largely restricted to endothelial 
cell. Besides causing proliferations, they induce endothelial cells to secrete 
proteinase. This is to degrade the basement membrane, promote endothelial cell 
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migration and direct vascular tube formation from the expanding endothelial cell 
population (Fujimoto et al., 2006). 
 
 Neovascularization has a dual effect on tumor growths by perfusion 
supplies nutrients and oxygen to tumor. The newly formed endothelial cells 
stimulate the growth of adjacent tumor cells by secreting polypeptides, such as 
insulin like growth factors and interleukin (Lee et al., 2002b). Studies have found 
that tumor growth, after reaching the size of about 1-2mm3 is strictly dependent 
on angiogenesis (Folkman & Shing, 1992). Angiogenesis is required not only for 
continued tumor growth but also for metastasis. Without access to the 
vasculature, the tumor cells cannot metastasize (Kumar et al., 2003b). 
  
Tumor angiogenesis is mainly evaluated on the basis of microvessel 
density (MVD). This can be measured using various endothelial markers such as 
CD31, CD34, ulex europaeus lectin I, von Willebrand factor (vWF) or usually 
known as factor VIII related antigen (FVIIIRA) (Dickinson et al., 1994). Factor VIII 
related antigen is a multimeric glycoprotein and was used to identify endothelial 
or megakaryocytic lineage of neoplasms. It has domain function to bind to 
platelet glycoprotein, collagen and heparin. Staining for factor VIII related antigen 
has been widely used to measure angiogenesis. Factor VIII related antigen 
remains a sensitive marker of benign blood vessels and has been used for the 
study of angiogenesis in various neoplasms such as breast cancer and cervical 
cancer (Weidner et al., 1991). 
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In cervical cancer, the measurement of the MVD has been found to 
provide prognostic information. Study by Tjalma et al. (1998) showed that there 
are correlation between tumor angiogenesis, expressed as microvessel density 
within the tumor stroma and pelvic lymph node metastasis in patients with early 
cervical cancer. They found that, the mean value of microvessel density in 
metastasized tumors (254 vessels per square millimeter of stroma) is significantly 
higher than in tumor with negative pelvic lymph nodes (144 vessels per square 
millimeter of stroma). Statistical multivariate analysis also found a significant 
correlation between MVD and disease free survival (Tjalma et al.,1998).  
 
In numerous invasive cancers, including those originating in the uterine 
cervix, increased vessel density is related to increased tumor growth, risk of 
metastasis, or decreased survival (Weidner, 1993; Dickinson et al., 1994; Tjalma 
et al., 1998). Other studies showed that patient with high tumor microvessel 
density have an increased risk to die from recurrent disease, as apposed to 
patient with a low tumor MVD, irrespective to pelvic node metastasis (Tjalma et 
al., 2001). Microvessel counts were also demonstrated to be increased in CIN III 
compared to CIN I by Weidner (1995).  
 
Among the advantages of angiogenesis research are ready accesses of 
drugs that target endothelium. Drug resistance is less likely to arise because the 
target is the proliferating endothelial cell rather than tumor cells with high 
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mutation rates and the capacity of the targeted drugs to block the tumor cells to 
spread via blood vessels and causing metastasis (Folkman, 1992).  
 
2.2 Objectives of the study 
 
The general objective of this study was to quantify the microvessel density 
(MVD) in normal cervix, cervix with CIN, cervix with HPV infection and cervix with 
SCC. The specific objectives are: 
 
a) To determine the MVD in normal cervix, CIN, and SCC. 
 
b) To determine the MVD in cervix with HPV infection in patients with CIN 
and SCC. 
 
c) To investigate the relationship of MVD with the risk of recurrence in CIN 
patients. 
 
d) To investigate the relations between MVD with tumor differentiation, 
deep stromal invasion, parametrial involvement, vascular space 
involvement and lymph node metastasis in patients with SCC and their 
association with the prognosis of the patients. 
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The hypothesis we wish to test is that the number of microvessels is directly 
proportional to the grade of the tumor and inversely proportional to the prognosis. 
 
2.3 Materials and methods 
 
2.3.1 Study design 
 
This is a retrospective study. The cases were tissue from patients either 
with CIN or SCC of cervix histopathologically diagnosed from 1998 to 2003 (6 
years duration). Inclusion criteria for this study were cases with paraffin blocks 
and fulfill all of this criteria; which area of interest still exist, follow-up of patients 
were available for at least one year, patients undergo treatment for cancer and 
only patients with SCC included in this study. 
 
Exclusion criteria for this study were cases where the paraffin blocks were 
not available, non-squamous cell carcinoma and cases which lack follow-up for 
one year or till their death which ever comes earlier. Patients with cancer of the 
cervix but did not undergo any treatment were also excluded from the study. The 
histopathology slides of those cases which fulfill these criteria were screened by 
pathologist (Dr. M. Madhavan) and the representative paraffin blocks were 
selected. From each chosen block, sections for haematoxylin and eosin (H&E) 
and immunohistochemistry were cut. Sections were stained with H&E to make 
sure that the area of interest still exists in the block. 
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 Then the immunohistochemistry sections were stained with anti FVIII 
related antigen antibody for determination of MVD. Clinical data were collected 
from patient’s medical record at the Hospital Universiti Sains Malaysia (HUSM) 
Registry Department. These include age of the patient, stage of the cancer, 
mode of treatment given, disease progression and the survival of the patients. 
Histological tumor cell types were assigned according to World Health 
Organization (WHO) classification. HPV status of the patients was determined by 
histology changes seen in the section by pathologist. 
 
For SCC cases, staging was reviewed based on FIGO (International 
Federation of Gynecology and Obstetrics) staging system. Local tumor 
characteristic such as lymph node status, vascular space involvement, deep 
stromal invasion and parametrial involvement were determined from pathology 
report. Regular follow-up consisted of physical examination, colposcopy and 
smears of the vaginal vault or cervix. If indicated, a biopsy specimen was taken. 
The appearance of dysplastic cells at the time of biopsy of the cervix or in the 
vaginal vault in the patient had undergone hysterectomy was considered as 
recurrent disease. The age at diagnosis, histology diagnosis, primary treatment 
and appearance of recurrence were determined from the report. Microvessel 
density (MVD) was correlated with the clinical parameters and the prognosis of 
the patients using SPSS statistical software (version 12.0.1 USA). The study 
design was summarized in figure 2.1. 
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Figure 2.1 Flow chart of the study design 
 
 
 
